Global Topical Corticosteroids Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Apr 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Topical Corticosteroids Market, By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Potency Class (Ultra-High, High,   Moderate, Low), Medication Type (Ointments, Creams, Liquid and Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others),  Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), End User (Hospital, Dermatology Clinics, Homecare, Others),  Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Topical Corticosteroids Market Market Analysis and Insights of Topical Corticosteroids Market

The topical corticosteroids market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 5,490.41 million by 2028 and will grow at a CAGR of 6.10% in the above mentioned forecast period.

Corticosteroids are the type of synthetic analogues of the natural hormones that are produced by the adrenal cortex. Topical corticosteroids are the kind of hydrocortisone-derivative compounds with separate anti-inflammatory potency.  They are largely used to treat many inflammatory skin diseases such as insect stings topical corticosteroids and contact curative.

The high incidence of skin diseases across the globe is amongst the significant factors expected to fuel the growth and demand of topical corticosteroids market. In addition, the rapid rise in geriatric population, increase in the incidence of chronic diseases and high demand for topical corticosteroids are also anticipated to push the growth in the global topical corticosteroids market over the forecast period of 2021 to 2028. Likewise, the rapid technological advancement and development and rise in number of skin disorders cases in children are also projected to lift the growth of the market. Furthermore, the rise in the health care expenditure, increase in the incidence of lifestyle-related diseases and high adoption of technologically advanced products are also expected to act as significant factors which will flourish the growth of the topical corticosteroids market.

The rapid surge in the investment in research and development and various companies are increasingly participating in mergers and acquisitions to build up their position thus, are expected to offer significant growth opportunities for the topical corticosteroids market in the forecast period of 2021 to 2028.

However, the  high price of the topical corticosteroids and their various side effects are estimated to limit the growth of the topical corticosteroids market, whereas, the expiry of patent for drugs and lack of reimbursement policies can challenge the growth of the topical corticosteroids market.

This topical corticosteroids market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the topical corticosteroids market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Topical Corticosteroids Market Scope and Market Size

The topical corticosteroids market is segmented on the basis of molecule name, potency class, medication type, application, distribution channel and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on molecule name, the topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone and others.
  • The potency class segment of the topical corticosteroids market is segmented into ultra-high, high, moderate, and low. Ultra high is further segmented into clobetasol propionate and diflorasone diacetate. High is further segmented into amcinonide, betamethasone dipropionate, desoximetasone, fluocinonide, halcinonide, and others. Moderate is further segmented into desoximetasone, fluocinolone acetonide, fludroxycortide, hydrocortisone valerate, triamcinolone acetonide and others. Low is further segmented into betamethasone valerate, desonide, fluocinolone acetonide, and others.
  • On the basis of medication type, the topical corticosteroids market is segmented into ointments, creams, liquid and solutions, lotions, gel, oils, pastes, sprays and others.
  • Based on application, the topical corticosteroids market is segmented intoacne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others.
  • On the basis of distribution channel, the topical corticosteroids market is segmented into hospital pharmacies, pharmacy stores, online pharmacies and others.
  • The topical corticosteroids market is also segmented on the basis of end user into hospital, dermatology clinics, homecare and others.

Topical Corticosteroids Market Country Level Analysis

The topical corticosteroids market is analyzed and market size insights and trends are provided by country, molecule name, potency class, medication type, application, distribution channel and end user as referenced above.

The countries covered in the topical corticosteroids market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the topical corticosteroids market owing to the rapid increase in the prevalence of skin disease and the high demand for new topical products for its treatment. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in the government support for research and development in healthcare domain along with the presence of large number of dermatology clinics and increase in the prevalence of skin diseases.

The country section of the topical corticosteroids market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Topical corticosteroids market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for topical corticosteroids market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the topical corticosteroids market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Topical Corticosteroids Market Share Analysis

Topical corticosteroids market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to topical corticosteroids market.

The major players covered in the topical corticosteroids market report are GlaxoSmithKline plc, Almirall, S.A.,Merck & Co., Inc., Bausch Health Companies Inc., Sandoz International GmbH, Pfizer Inc., AstraZeneca, Sanofi, Bayer AG, McKesson Medical-Surgical Inc.,Regeneron Pharmaceuticals Inc., Allergan,AbbVie Inc.,Galderma Laboratories, L.P., Novartis AG,LEO Pharma A/S,  Cipla Inc.,Johnson & Johnson Services, Inc.,Bristol-Myers Squibb Company andMylan N.V.,among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Topical Corticosteroids Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE LIST GLOBAL TOPICAL CORTIOCOSTEROIDS MARKET

TABLE 1 PRICE OF VARIOUS PRODUCTS CONTAINING TOPICAL CORTICOSTEROIDS AND ANTIMICROBIALS TABLE 2 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 3 GLOBAL FLUDROXYCORTIDE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 4 GLOBAL TRIAMCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 5 GLOBAL FLUOCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 6 GLOBAL ANTISEPTICS MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 7 GLOBAL BETAMETHASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 8 GLOBAL CLOBETASONE PROPIONATE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 9 GLOBAL CLOBETASONE BUTYRATE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 10 GLOBAL HALOBETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 11 GLOBAL MOMETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 12 GLOBAL OTHERS MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 13 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 14 GLOBAL ULTRA HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 15 GLOBAL ULTRA HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) TABLE 16 GLOBAL HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 17 GLOBAL HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) TABLE 18 GLOBAL MODERATE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 19 GLOBAL MODERATE HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) TABLE 20 GLOBAL MILD TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 21 GLOBAL MILD POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) TABLE 22 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 23 GLOBAL ACNE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 24 GLOBAL DERMATITIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 25 GLOBAL PSORIASIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 26 GLOBAL SKIN INFECTION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 27 GLOBAL HYPERPIGMENTATION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 28 GLOBAL MELASMA TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 29 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS APPLICATION MARKET, BY REGION, 2015 – 2024 (USD BILLION) TABLE 30 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015– 2024 (USD MILLION) TABLE 31 GLOBAL OINTMENT TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 32 GLOBAL CREAMS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 33 GLOBAL LIQUID & SOLUTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 34 GLOBAL LOTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 35 GLOBAL GEL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 36 GLOBAL OILS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 37 GLOBAL PASTES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 38 GLOBAL SPRAYS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 39 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 40 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015– 2024 (USD MILLION) TABLE 41 GLOBAL HOSPITAL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 42 GLOBAL DERMATOLOGY CLINICS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 43 GLOBAL HOMECARE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 44 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 45 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 46 GLOBAL HOSPITAL PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 47 GLOBAL PHARMACY STORES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 48 GLOBAL ONLINE PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 49 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 50 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 51 GLOBAL OVER THE COUNTER (OTC)BASED TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 52 GLOBAL PRESCRIPTION BASED TOPICAL CORTICOSTEROIDS MARKET,BY REGION, 2015 – 2024 (USD MILLION) TABLE 53 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 54 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015– 2024 (USD MILLION) TABLE 55 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 56 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 57 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 58 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 59 NORTH AMERICA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 60 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 61 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 62 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 63 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 64 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 65 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 66 U.S. TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 67 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 68 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 69 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 70 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 71 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 72 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 73 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 74 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 75 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 76 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 77 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 78 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 79 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 80 MEXICO TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 81 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 82 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 83 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015– 2024 (USD MILLION) TABLE 84 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 85 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 86 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 87 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 88 EUROPE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 89 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 90 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 91 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 92 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 93 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 94 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 95 GERMANY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 96 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 97 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 98 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 99 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 100 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 101 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 102 FRANCE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 103 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 104 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 105 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 106 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 107 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 108 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 109 U.K. TOPICAL CONTORTIONISTS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 110 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 111 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 112 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 113 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 114 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 115 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 116 ITALY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 117 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 118 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 119 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 120 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 121 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 122 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 123 SPAIN TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 124 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 125 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 126 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 127 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 128 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 129 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 130 RUSSIA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 131 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 132 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 133 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 134 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 135 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 136 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 137 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 138 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 139 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 140 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 141 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 142 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 143 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 144 BELGIUM TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 145 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 146 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 147 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 148 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 149 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 150 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 151 NETHERLANDS TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 152 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 153 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 154 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 155 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) TABLE 156 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 157 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 158 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) TABLE 159 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 160 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 161 REST OF EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) TABLE 162 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 163 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 164 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 165 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 166 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 167 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 168 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 169 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 170 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 171 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 172 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 173 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 174 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 175 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 176 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 177 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 178 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 179 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 180 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 181 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 182 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 183 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 184 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 185 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 186 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 187 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 188 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 189 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 190 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 191 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 192 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 193 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 194 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 195 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 196 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 197 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 198 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 199 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 200 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 201 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 202 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 203 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 204 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 205 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 206 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 207 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 208 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 209 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 210 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 211 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 212 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 213 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 214 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 215 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 216 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 217 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 218 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 219 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 220 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 221 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 222 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 223 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 224 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 225 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 226 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 227 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 228 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 229 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 230 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 231 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 232 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 233 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 234 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION) TABLE 235 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 236 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) TABLE 237 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) TABLE 238 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) TABLE 239 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 240 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) TABLE 241 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015-2024,(USD MILLION) TABLE 242 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 243 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION) TABLE 244 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 245 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 246 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION) TABLE 247 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 248 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 249 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 250 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION) TABLE 251 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 252 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 253 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION) TABLE 254 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION) TABLE 255 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 256 REST OF SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 257 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015-2024,(USD MILLION) TABLE 258 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 259 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION) TABLE 260 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 261 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 262 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION) TABLE 263 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015-2024 (USD MILLION) TABLE 264 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 265 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION) TABLE 266 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION) TABLE 267 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION) TABLE 268 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) TABLE 269 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION) TABLE 270 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015-2024 (USD MILLION) TABLE 271 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) TABLE 272 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions